transferrin (Advantek)

N/A

Report date: 2025/03/20 09:16:24
NME

Base Information

Drug Nametransferrin (Advantek)
Drug Alias Nametransferrin (human)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransferrins modulators
TargetsTransferrins
Therapy Area/IndicationsThalassemiaAnemia, Hemolytic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdvantek Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdvantek Biologics Ltd
Inactive CompaniesN/A
Active IndicationsThalassemiaAnemia, Hemolytic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A